The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults

NCT ID: NCT01767025

Last Updated: 2013-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the influence of oxytocin on automatic imitation behaviour is investigated. Healthy adults will be administered with either oxytocin or a placebo, and will perform an imitation-inhibition task (as a measure of automatic imitation behaviour). To determine the specificity of the oxytocin effect, an unrelated cognitive task (Stroop task) will also be presented.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxytocin

Oxytocin 24 IU (3 puffs) per nostril

Group Type EXPERIMENTAL

Oxytocin

Intervention Type DRUG

Sea water

Sea water 3 puffs per nostril

Group Type PLACEBO_COMPARATOR

Sea water

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxytocin

Intervention Type DRUG

Sea water

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* non-smoker

Exclusion Criteria

* no pacemaker, deep brain stimulation electrodes or other stimulation devices
* normal neurological history (no brain operations, migraine, epilepsy, alcoholism
* no epilepsy in family
* no chronic disease(s) that require constant medication (asthma, hypertension, diabetes)
* no medication 24h prior to experiment
* no alcohol or caffeine 2h prior to experiment
* no sleep deprivation 24h prior to experiment
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Research Foundation Flanders

OTHER

Sponsor Role collaborator

University Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guy T'Sjoen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Ghent University, Faculty of Endrocrinology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ghent University, Faculty of Psychology and Educational Sciences

Ghent, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012/550

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oxytocin and Social Behavior Over the Lifespan
NCT00914953 COMPLETED EARLY_PHASE1
Oxytocin and Emotion Recognition
NCT01216605 COMPLETED PHASE4